title: Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine.
authors.forename: Ronald D
authors.initials: RD
authors.lastname: Miller
authors.forename: Theresa A
authors.initials: TA
authors.lastname: Ward
mesh_terms: D004558:Electric Stimulation; D019317:Evidence-Based Medicine; D006801:Humans; D008991:Monitoring, Physiologic; D019148:Neuromuscular Blockade / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D010525:Peripheral Nerves / Q000187:drug effects / Q000502:physiology; D011183:Postoperative Complications / Q000139:chemically induced / Q000628:therapy
chemical_list: D003473:Neuromuscular Nondepolarizing Agents